Ceremed, Inc. is a privately held California corporation founded in 2002 by a group of experts in the fields of physiology, biophysics, chemistry, hematology and reconstructive plastic surgery that hold unique expertise in the field of implantable polymers. The company’s focus involves partnerships with leading universities and medical device/pharmaceutical manufacturers to produce breakthrough products using proprietary polymer technologies. This strategy allows Ceremed to concentrate on product development, clinical trials, the development of strong intellectual property positions and regulatory approvals. Ceremed is a leading innovator in the development of next generation medical products using proprietary polymer technology. These products include Ostene®, Porous Polyethylene (PPE) Implants for reconstructive surgery, AOC PolymerBlend™ coatings and AOC PolymerBlend™ carrier systems for bioactive ingredients. Ceremed maintains substantial IP positions within the biocompatible polymer and device space with numerous patents covering a wide variety of technologies and applications.